Skip to main content
. 2022 Apr 19;12:6436. doi: 10.1038/s41598-022-10477-5

Table 1.

Included studies.

First author, year Assigned time since CPB cessation (h) Sample size AKI Prevalence TP FP FN TN pNGAL cut-off (ng/mL) Sensitivity Specificity PPV NPV AUROC (95% CI)
Merkle, 201942  < 4 58 0.36 15 3 6 34 226.98 0.71 0.92 0.83 0.85 0.846 (0.727–0.927)
24 58 0.36 18 8 3 29 115.87 0.86 0.78 0.69 0.91 0.891 (0.781–0.957)
Introcaso, 201843 4–8 69 0.35 18 18 6 27 154 0.76 0.59 0.5 0.81 0.71 (0.60–0.82)
Guerci, 201844 4–8 50 0.36 15 5 3 27 112 0.83 0.84 0.75 0.9 0.9 (0.81–0.98)
Schley, 201545  < 4 110 0.34 28 18 9 55 173.43 0.76 0.75 0.609 0.859 0.81 (0.73–0.90)
4–8 110 0.34 29 18 8 55 178.20 0.78 0.75 0.617 0.873 0.83 (0.75–0.91)
24 110 0.34 32 18 5 55 137.61 0.86 0.75 0.640 0.916 0.84
Park, 201546 4–8 112 0.12 8 11 5 88 168.5 0.62 0.89 0.421 0.946 0.81 (0.68–0.95)
Kidher, 201447  < 4 53 0.30 13 4 3 33 150 0.80 0.89 0.765 0.917 0.83 (0.70–0.95)
Ghonemy, 201430 4–8 50 0.34 17 3 0 30 62 0.98 0.92 0.842 0.967 Not stated
 < 4 50 0.34 16 2 1 31 62 0.94 0.94 0.888 0.968 Not stated
Parikh, 201129  < 4 1219 0.05 30 209 30 950 293 0.50 0.82 0.126 0.969 0.7 (SE 0.04)
Perry, 201048  < 4 879 0.09 29 149 46 655 353.5 0.39 0.82 0.163 0.934 0.641 (0.58–0.71)
24 879 0.09 42 242 33 562 353.5 0.55 0.70 0.148 0.945 0.670 (0.60–0.74)
Haase, 200949 4–8 100 0.46 34 14 12 40 150.0 0.73 0.74 0.708 0.769 0.77 (0.63–0.91)
Haase-Fielitz, 200918 4–8 100 0.23 18 17 5 60 150.0 0.79 0.78 0.52 0.93 0.80 (0.63–0.96)
24 100 0.23 21 18 2 59 150.0 0.91 0.76 0.53 0.97 0.87 (0.78–0.96)
Perrotti, 201550 24 166 0.31 31 27 21 87 258 0.60 0.76 0.534 0.806 0.7
12 166 0.31 43 48 9 66 173 0.82 0.58 0.473 0.88 0.7
4–8 166 0.31 41 48 11 66 155 0.79 0.58 0.461 0.857 0.7
 < 4 166 0.31 28 33 24 81 178 0.54 0.71 0.459 0.771 0.6
Gaipov, 201551 12 60 0.67 21 5 19 15 199 0.52 0.73 0.808 0.441 0.649 (0.507–0.774)
24 60 0.67 32 11 8 9 175.4 0.79 0.46 0.744 0.529 0.646 (0.504–0.772)
Prabhu, 201052 4–8 30 0.27 8 2 0 20 229 1.00 0.91 0.794 1 0.98
Tuladhar, 200953  < 4 50 0.18 7 14 2 27 426 0.80 0.67 0.333 0.931 0.85 (0.73–0.97)
Othman, 202128 4–8 25 0.28 7 2 0 16 145 1.00 0.89 0.778 1 0.965